Preferred Label : Alexander disease;
Symbol : ALXDRD;
CISMeF acronym : ALXDRD;
Type : Phenotype, molecular basis known;
Description : In decreasing order of frequency, 3 forms of Alexander disease are recognized, based
on age of onset: infantile, juvenile, and adult. Younger patients typically present
with seizures, megalencephaly, developmental delay, and spasticity. In older patients,
bulbar or pseudobulbar symptoms predominate, frequently accompanied by spasticity.
The disease is progressive, with most patients dying within 10 years of onset. Imaging
studies of the brain typically show cerebral white matter abnormalities, preferentially
affecting the frontal region (Gorospe et al., 2002). All 3 forms have been shown to
be caused by mutations in the;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutations in the glial fibrillary acidic protein gene (GFAP, 137780.0001);
Laboratory abnormalities : Elevated CSF protein; Presence of glial fibrillary acidic proteins (GFAP) in astrocytes; Presence of Rosenthal fibers (cytoplasmic inclusions) in astrocytes;
Prefixed ID : #203450;
Origin ID : 203450;
UMLS CUI : C0270726;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)